share_log

JMP Securities Maintains Outperform on Enanta Pharma, Lowers Price Target to $23

Benzinga ·  Nov 21, 2023 06:51

JMP Securities analyst Roy Buchanan maintains Enanta Pharma (NASDAQ:ENTA) with a Outperform and lowers the price target from $42 to $23.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment